Record Revenue and Growth
Calian Group delivered record results with the highest revenue quarter in its 43-year history and the second highest adjusted EBITDA. Revenues increased by 12% to $203 million in Q4, with a return to positive organic growth. The fiscal year 2025 revenues were up 4% to $774 million, a new record for the company.
Defense Solutions Expansion
Defense Solutions continues to lead with double-digit growth and now represents 50% of consolidated revenues. Revenues grew 17% year-over-year, driven by increased demand across Canada, the U.K., and Europe. Significant contract wins include agreements with NATO and Allied countries, and a $250 million expansion to the health services contract with Canadian Armed Forces.
Global Presence and Strategic Acquisitions
48% of Q4 revenues were generated outside Canada, marking the highest quarter in terms of international revenue. Strategic acquisitions like AMS and InField Scientific have strengthened Calian's capabilities, particularly in defense and health care.
Strong Cash Flow and Shareholder Returns
Calian generated $45 million in cash flow from operations and maintained working capital efficiency below 10%. The company returned value to shareholders with $13 million in dividends and $26 million in share buybacks, representing approximately 5% of shares outstanding.
Positive Outlook and Strategic Direction
For fiscal year 2026, Calian expects double-digit growth in both revenue and adjusted EBITDA. The company plans to focus on high-growth vertical markets like defense and space, streamline operations, and invest with discipline.